Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyperpolarized Pyruvate Imaging in Pediatric Brain Tumors
NCT02947373Phase 1Completed
- Sponsor
- University of California, San Francisco
- Start
- Jan 2017
- Primary completion
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of [1-13C]pyruvate in brain tumor, sponsored by University of California, San Francisco. Primary endpoint: Number of Participants With Adverse Events at 9 months. Started Jan 2017; status: completed.
02
Drugs
[1-13C]pyruvate
03
Conditions
brain tumor
Beyond the preview
Go deeper on NCT02947373.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02947373.